Top News

Biotech, pharma trade groups argue Nevada law targeting diabetes medicines ‘unconstitutional’

Jessica Karmasek Sep. 14, 2017, 4:14pm

The plaintiffs, Pharmaceutical Research and Manufacturers of America, or PhRMA, and Biotechnology Innovation Organization, or BIO, filed their lawsuit against Nevada Gov. Brian Sandoval and the head of the state’s Department of Health and Human Services in the U.S. District Court for the District of Nevada Sept. 1. They allege Senate Bill 539, signed into law by Sandoval in June, will violate patent rights and negate trade secret protection for designated diabetes medicines.